321 Columbus Avenue
United States - Map
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard and MGuard prime embolic protection stents for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing PVGuard for use in peripheral vascular applications. It operates in the Middle East, Germany, Belarus, Spain, the Russian Federation, and internationally. The company is headquartered in Boston, Massachusetts.
|Mr. Alan W. Milinazzo ,
Chief Exec. Officer, Pres and Director
|Mr. Craig Shore ,
Chief Financial Officer, Chief Admin. Officer, Sec. and Treasurer
|Dr. James J. Barry Ph.D.,
Chief Operating Officer, Exec. VP and Director
|Mr. Eli Bar B.Sc.,
Chief Technology Officer, Chief Technical Officer of InspireMD Ltd and Sr. VP of R&D - InspireMD Ltd
|Ms. Gwen K. Bame ,
VP of Corp. Devel.
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|